In addition, C20/C22 treatment inhibited tumor angiogenesis (Figure 10G) and tumor cell proliferation (Figure 10H), which could be attributed to the decreased expression of CD31 and Ki67, respectively. The gene discussed is MKI67; the disease is neoplasm.